CONMED CORPORATION Shareholders' Equity
CONMED CORPORATION (CNMD) had Shareholders' Equity of $1.04 billion as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-07-29
- 2026-06-30: Stockholders' Equity Attributable to Parent $1.04B.
- 2026-03-31: Stockholders' Equity Attributable to Parent $1.02B.
- 2025-12-31: Stockholders' Equity Attributable to Parent $1.03B.
- 2025-09-30: Stockholders' Equity Attributable to Parent $1.01B.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $1.04B 10-Q · filed 2026-07-29 |
| 2026-03-31 | $1.02B 10-Q · filed 2026-07-29 |
| 2025-12-31 | $1.03B 10-Q · filed 2026-07-29 |
| 2025-09-30 | $1.01B 10-Q · filed 2025-11-06 |
| 2025-06-30 | $1.00B 10-Q · filed 2026-07-29 |
| 2025-03-31 | $977.64M 10-Q · filed 2026-07-29 |
| 2024-12-31 | $962.68M 10-Q · filed 2026-07-29 |
| 2024-09-30 | $932.90M 10-Q · filed 2025-11-06 |
| 2024-06-30 | $881.83M 10-Q · filed 2025-11-06 |
| 2024-03-31 | $854.66M 10-Q · filed 2025-11-06 |
| 2023-12-31 | $834.22M 10-K · filed 2026-02-17 |
| 2023-09-30 | $796.21M 10-Q · filed 2024-10-31 |
| 2023-06-30 | $780.19M 10-Q · filed 2024-10-31 |
| 2023-03-31 | $752.45M 10-Q · filed 2024-10-31 |
| 2022-12-31 | $745.54M 10-K · filed 2026-02-17 |
| 2022-09-30 | $716.34M 10-Q · filed 2023-10-26 |
| 2022-06-30 | $672.97M 10-Q · filed 2023-10-26 |
| 2022-03-31 | $789.55M 10-Q · filed 2023-10-26 |
| 2021-12-31 | $785.43M 10-K · filed 2025-02-18 |
| 2021-09-30 | $755.68M 10-Q · filed 2022-10-27 |
| 2021-06-30 | $744.50M 10-Q · filed 2022-10-27 |
| 2021-03-31 | $725.57M 10-Q · filed 2022-10-27 |
| 2020-12-31 | $709.04M 10-K · filed 2024-02-28 |
| 2020-09-30 | $683.14M 10-Q · filed 2021-10-28 |
| 2020-06-30 | $674.90M 10-Q · filed 2021-10-28 |
| 2020-03-31 | $701.63M 10-Q · filed 2021-10-28 |
| 2019-12-31 | $710.47M 10-K · filed 2023-02-21 |
| 2019-09-30 | $700.92M 10-Q · filed 2020-10-29 |
| 2019-06-30 | $697.01M 10-Q · filed 2020-10-29 |
| 2019-03-31 | $693.06M 10-Q · filed 2020-10-29 |
| 2018-12-31 | $662.27M 10-K · filed 2022-02-22 |
| 2018-09-30 | $652.66M 10-Q · filed 2019-10-31 |
| 2018-06-30 | $648.19M 10-Q · filed 2019-10-31 |
| 2018-03-31 | $642.63M 10-Q · filed 2019-10-31 |
| 2017-12-31 | $631.43M 10-K · filed 2021-02-22 |
| 2017-09-30 | $589.67M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $582.36M 10-Q · filed 2017-07-27 |
| 2017-03-31 | $575.52M 10-Q · filed 2017-04-27 |
| 2016-12-31 | $580.58M 10-K · filed 2020-02-24 |
| 2016-09-30 | $584.17M 10-Q · filed 2016-10-28 |
| 2016-06-30 | $579.73M 10-Q · filed 2016-07-28 |
| 2016-03-31 | $582.29M 10-Q · filed 2016-05-02 |
| 2015-12-31 | $585.07M 10-K · filed 2019-02-25 |
| 2015-09-30 | $577.42M 10-Q · filed 2015-10-23 |
| 2015-06-30 | $578.09M 10-Q · filed 2015-07-27 |
| 2015-03-31 | $574.09M 10-Q · filed 2015-04-24 |
| 2014-12-31 | $581.30M 10-K · filed 2018-02-26 |
| 2014-09-30 | $592.72M 10-Q · filed 2014-10-24 |
| 2014-06-30 | $602.15M 10-Q · filed 2014-07-25 |
| 2014-03-31 | $595.47M 10-Q · filed 2014-04-25 |
| 2013-12-31 | $606.32M 10-K · filed 2017-02-27 |
| 2013-09-30 | $592.23M 10-Q · filed 2013-10-28 |
| 2013-06-30 | $584.67M 10-Q · filed 2013-07-29 |
| 2013-03-31 | $597.58M 10-Q · filed 2013-04-29 |
| 2012-12-31 | $607.00M 10-K · filed 2016-02-23 |
| 2012-09-30 | $602.45M 10-Q · filed 2012-10-29 |
| 2012-06-30 | $593.38M 10-Q · filed 2012-07-30 |
| 2012-03-31 | $586.73M 10-Q · filed 2012-05-01 |
| 2011-12-31 | $573.07M 10-K · filed 2015-02-23 |
| 2011-09-30 | $609.75M 10-Q · filed 2011-11-01 |
| 2011-06-30 | $616.71M 10-Q · filed 2011-08-09 |
| 2010-12-31 | $586.56M 10-K · filed 2014-02-24 |
| 2009-12-31 | $576.51M 10-K · filed 2013-02-25 |
| 2008-12-31 | $540.22M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |